Cerity Partners LLC Sells 3,523 Shares of Integer Holdings Corporation (NYSE:ITGR)

Cerity Partners LLC lessened its stake in Integer Holdings Corporation (NYSE:ITGR) by 11.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 27,658 shares of the medical equipment provider’s stock after selling 3,523 shares during the quarter. Cerity Partners LLC’s holdings in Integer were worth $3,264,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nisa Investment Advisors LLC increased its holdings in Integer by 1.0% in the 1st quarter. Nisa Investment Advisors LLC now owns 20,450 shares of the medical equipment provider’s stock valued at $2,413,000 after acquiring an additional 197 shares during the last quarter. TD Private Client Wealth LLC grew its position in shares of Integer by 5.8% during the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider’s stock valued at $180,000 after purchasing an additional 83 shares in the last quarter. OneDigital Investment Advisors LLC grew its position in shares of Integer by 14.1% during the first quarter. OneDigital Investment Advisors LLC now owns 1,969 shares of the medical equipment provider’s stock valued at $232,000 after purchasing an additional 243 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Integer by 2.8% in the first quarter. Principal Financial Group Inc. now owns 187,290 shares of the medical equipment provider’s stock worth $22,102,000 after purchasing an additional 5,023 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Integer in the first quarter worth about $579,000. Institutional investors own 99.29% of the company’s stock.

Insider Transactions at Integer

In related news, Director Martin C. Maxwell sold 8,720 shares of the company’s stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director owned 22,170 shares of the company’s stock, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Donald J. Spence sold 14,739 shares of the stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the sale, the director owned 18,781 shares of the company’s stock, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 362,434 shares of company stock valued at $44,577,115. Corporate insiders own 2.16% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Wall Street Zen upgraded Integer from a “sell” rating to a “hold” rating in a report on Monday, May 19th. Truist Financial set a $150.00 price target on shares of Integer and gave the company a “buy” rating in a research note on Friday, April 25th. KeyCorp lowered their price objective on shares of Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Citigroup upgraded shares of Integer from a “hold” rating to a “strong-buy” rating and boosted their target price for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, Raymond James Financial upped their target price on shares of Integer from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, April 25th. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $146.25.

Integer Stock Down 1.9%

Integer stock opened at $112.51 on Friday. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78. The business’s 50-day moving average price is $119.65 and its 200 day moving average price is $124.45. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 53.32, a price-to-earnings-growth ratio of 0.99 and a beta of 0.98.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. During the same period in the prior year, the business posted $1.14 earnings per share. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.